| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |